McKesson Corporation

(New York Stock Exchange)
Back to all articles
Slightly Bullish +25

MCK Dividend History: 0.37% Yield Β· $0.94 quarterly - MerryDiv

AI-generated analysis

πŸ“ˆ McKesson has increased its dividend for 26 consecutive years, securing Dividend Aristocrat status.

πŸ’° The company pays a quarterly dividend of $0.94 per share with an annualized rate of $3.40.

πŸ“‰ The current dividend yield is 0.37%, which is low but sits above the 5-year average of 0.26%.

πŸ›‘οΈ McKesson maintains a conservative 8.6% payout ratio, retaining most earnings to fund future growth.

πŸ“Š Historical dividend growth from 2011 to 2025 shows a CAGR of 10.3%, with per-share payments rising from $0.78 to $3.06.

🏒 The business spans four segments including U.S. Pharmaceutical, Medical-Surgical Solutions, international markets, and RxTS.

πŸ“‰ McKesson has a low beta of 0.307, indicating the stock moves significantly less than the broader market.

Bullish Signals
  • The company has achieved Dividend Aristocrat status with 26 consecutive years of dividend increases.
  • McKesson maintains a highly conservative 8.6% payout ratio, providing substantial room to sustain or grow the dividend without financial strain.
  • Historical performance shows a strong 10.3% compound annual growth rate (CAGR) in dividends from 2011 to 2025.
  • The current yield of 0.37% is higher than the 5-year average of 0.26%, indicating recent price appreciation relative to dividend payments.
Risk Factors
  • The current dividend yield of 0.37% is very low, offering minimal immediate income for investors seeking high-yield returns.
  • The exceptionally low payout ratio means the stock's total return relies heavily on share price appreciation rather than current cash flow distribution.
Full Analysis
McKesson Corporation (MCK) is a global healthcare distribution giant with a history of consistent dividend growth, having increased its payout for 26 consecutive years to earn Dividend Aristocrat status. As of September 2026, the company pays a quarterly dividend of $0.94, resulting in an annualized rate of $3.40 per share and a current yield of 0.37% based on a stock price near $908. The company operates through four primary segments: U.S. Pharmaceutical distribution, Medical-Surgical Solutions, international operations, and Prescription Technology Solutions (RxTS). This diversified business model spans pharmaceuticals, medical supplies, and technology services for pharmacies and healthcare providers, supported by a conservative 8.6% dividend payout ratio that prioritizes earnings retention over current yield expansion. McKesson's dividend growth has been robust historically, achieving a compound annual growth rate (CAGR) of 10.3% from 2011 to 2025. While the current yield is low compared to high-yield alternatives, the stock offers stability with a beta of 0.307 and provides investors exposure to recurring demand in healthcare distribution through a strategy focused on long-term dividend expansion rather than immediate income generation.